Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A patient-centric approach to optimise insulin therapy in Asia.
Goh SY, Ang E, Bajpai S, Deerochanawong C, Hong EG, Hussein Z, Joshi S, Kamaruddin NA, Kho S, Kong AP, Pan CY, Perfetti R, Vichayanrat A, Vlajnic A, Chan JC. Goh SY, et al. Among authors: vlajnic a. J Diabetes Complications. 2016 Aug;30(6):973-80. doi: 10.1016/j.jdiacomp.2016.05.019. Epub 2016 May 24. J Diabetes Complications. 2016. PMID: 27288201 No abstract available.
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy.
Hollander P, Sugimoto D, Vlajnic A, Kilo C. Hollander P, et al. Among authors: vlajnic a. J Diabetes Complications. 2015 Nov-Dec;29(8):1266-71. doi: 10.1016/j.jdiacomp.2015.05.022. Epub 2015 Jun 5. J Diabetes Complications. 2015. PMID: 26281972 Clinical Trial.
Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
Polonsky W, Traylor L, Gao L, Wei W, Ameer B, Stuhr A, Vlajnic A. Polonsky W, et al. Among authors: vlajnic a. J Diabetes Complications. 2017 Mar;31(3):562-568. doi: 10.1016/j.jdiacomp.2016.11.018. Epub 2016 Dec 8. J Diabetes Complications. 2017. PMID: 28040350
Validation of the SoloSTAR insulin pen.
Schwartz S, Vlajnic A. Schwartz S, et al. Among authors: vlajnic a. Diabetes Technol Ther. 2008 Oct;10(5):351-7. doi: 10.1089/dia.2008.0079. Diabetes Technol Ther. 2008. PMID: 18715210 Clinical Trial.
Effect of gender on treatment outcomes in type 2 diabetes mellitus.
McGill JB, Vlajnic A, Knutsen PG, Recklein C, Rimler M, Fisher SJ. McGill JB, et al. Among authors: vlajnic a. Diabetes Res Clin Pract. 2013 Dec;102(3):167-74. doi: 10.1016/j.diabres.2013.10.001. Epub 2013 Oct 8. Diabetes Res Clin Pract. 2013. PMID: 24183259
23 results